CLINICAL TRIALS PROFILE FOR PHOSLO
✉ Email this page to a colleague
All Clinical Trials for PHOSLO
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00211939 ↗ | CARE-2 (Calcium Acetate [PhosLo®]/Sevelamer[Renagel®] Evaluation Study 2) for Heart Calcification in Dialysis Patients | Completed | Nabi Biopharmaceuticals | Phase 4 | 2005-01-01 | The purpose of the study is to evaluate the effects of two phosphate binders, PhosLo and sevelamer, on heart calcification in dialysis patients. The study will use a non-invasive technique, electron beam computed tomography (CT) scanning, to measure calcium in the coronary arteries, the aortic valve, and the mitral valve. |
NCT00211978 ↗ | EPIC(Effect of PhosLo on Phosphorus Levels in Chronic Kidney Disease) | Completed | Nabi Biopharmaceuticals | Phase 3 | 2005-05-01 | The purpose of this study is to determine if calcium acetate (PhosLo) can control serum phosphorus in pre-dialysis patients with moderate to severe impairment of kidney function. |
NCT00742820 ↗ | Bioequivalence Study Comparing Calcium Acetate Oral Solution Versus Calcium Acetate Gelcaps in Healthy Volunteers | Completed | Fresenius Medical Care North America | Phase 1 | 2008-08-01 | To compare the bioequivalence of calcium acetate oral solution vs. calcium acetate gelcaps in healthy volunteers with calcium citrate as a positive control. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for PHOSLO
Condition Name
Clinical Trial Locations for PHOSLO
Trials by Country
Clinical Trial Progress for PHOSLO
Clinical Trial Phase
Clinical Trial Sponsors for PHOSLO
Sponsor Name